Xenopus laevis oocytes (7, 8) . Recently, the human renal sodium phosphate cotransporter has been cloned using the Xenopus oocytes expression system (9) . The X-linked hypophosphatemia represents the most common form of vitamin D-resistant rickets in man (10) , and it is thought that a defect in the renal Na" phosphate cotransporter might be responsible for the disorder (II). Because the disorder has as an X-linked mode of inheritance, we postulated that the renal phosphate transporter is encoded on the X chromosome. Our studies were designed to ascertain the chromosomal location of the human renal phosphate transporter as an initial step in determining its role in this disease.
Amplification of a genom ic DNA encoding for the phosphate transporter. Two sets of 20 oligonucleotide primers were used to amplify the phosphate transporter gene from human genomic DNA obtained from blood. The first set included the primers (5' CTCTACCTCTTCGTCTGCTC 3') and (5' GAGTGATGT-GGTGCAGGTAG 3'). The second set included the primers (5' CACTGACCTGCAGACCTCAT 3') and (5' GGAGCAGAC-GAAGAGGTAGA 3'). A PCR optimizer kit (Invitrogen, San Diego, CA) was used to amplify the phosphate transporter gene with human genomic DNA used as the template. The optimal PCR reaction mixture contained 200 ng of DNA, 0.02~M each primer, 200~M deoxynucleotides and 2.5 U of Taq DNA polymerase in 50~L of 60 mM Tris-HCI, 15 mM NH.SO•• and 2 mM MgCh at pH 8.5. The reaction conditions were as follows: 96°C for 5 min followed by 31 cycles of 1.5 min of denaturation at 94°C, annealing 1 min at 63°C, followed by a 3-min extension at 72°C with a final extension time of 10 min at 72°C. PCR products were analyzed on a 1% agarose gel with ethidium bromide staining.
Chromosomal localization. Two methods were used to determine the chromosomal assignment of the renal phosphate gene. First. somatic cell hybrid panels were probed with a 2-kb human genomic DNA fragment that was labeled using random primers with 32p deoxycytidine triphosphate. DNA from somatic cell hybrid panels was subjected to digestion by BamHI restriction endonuclease (somatic cell hybrids panel catalog S440 I-BamHl, Oncor Inc., Gaithersburg, MD). The blots were prehybridized for 4 h at 45°C with hybrisol I (Oncor Inc.) and hybridizations were done overnight at 45°C. The blots were washed with 0.1x SSC (3 M sodium chloride, 0.3 M sodium citrate at pH 7.0) and O. I% SDS three times at room temperature and I h at 52°C, then exposed to film under conditions recommended by the commercial supplier.
The second method was PCR amplification of somatic cell hybrid DNA using the two sets of primers used in the amplifi- . Biochemically, these patients exhibit hypophosphatemia due to a defect in the renal tubular reabsorption of phosphate. The human cDNA encoding for the renal phosphate transporter has been recently cloned using the expression system in the Xenopus lu,is oocytes. Because hypophosphatemic vitamin D-resistant rickets has an X~linked mode of transmission, we hypothesized that the gene encoding the renal phosphate transporter might map to the X chromosome. In this report, we determined the chromosomal localization of the human renal phosphate transporter using three independent methods. First, DNA from somatic cell hybrid panels was examined by Southern blotting for the phosphate transporter. Second, the polymerase chain reaction was used to amplify DNA from somatic cell hybrids. Third, fluorescent in situ hybridization was used to sublocalize the renal phosphate transporter. All three methods localized the renal phosphate transporter to chromosome 5q13. Our results indicate that either derangement of a gene other than the phosphate transporter gene that is encoded on chromosome 5 is responsible for X-linked hypophosphatemic rickets or, alternatively, a gene encoded on the X chromosome has an epistatic effect on the expression of the renal phosphate transporter on chromosome 5. (Pediatr Res 35: 510-513, 1994)
Phosphate transport across the brush-border membranes of enterocytes and kidney proximal tubule cells occurs by a sodiumdependent process maintained by Na+-K+-ATPase at the basolateral membranes (I). This coupled sodium phosphate transport process has been described in several avian and mammalian species including man (2-4) . The sodium phosphate cotransporter is influenced by the pH of the medium and exhibits saturation kinetics (1) (2) (3) (4) (5) (6) . The transporter has been expressed in 
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Human hypophosphatemic vitamin D-resistant rickets was described originally by Albright et al. in 1937 (13) . The X-linked mode of inheritance was shown in 1958 by Winters et al. (14) . Biochemically, patients have a low serum phosphate level, a high serum alkaline phosphatase level and an increased tubular excretion of phosphate . Phenotypically, patients have growth retardation and lower-limb skeletal abnormalities (10) .
A hypophosphatemic mouse model (Hyp mouse) was described by Eicher et al. in 1976 (15) . The Hyp mouse appears to be the animal model for the human disease because it has similar biochemical and phenotypic changes and its mode of inheritance is X-linked. The defect in the Hyp mouse and in humans with X-linked hypophosphatemia is thought to be related to an intrinsic defect in the sodium phosphate transporter (7, II , 16) or
RESULTS
Cloning of a fragment of the phosphate gene. Using the first set of primers, we have amplified a 600-bp fragment from genomic DNA rather than the 384-bp size expected from the cDNA sequence. Using the second set of primers, we amplified a 2-kb fragment rather than the expected 414 bp from the cDNA sequence, suggesting the piece we amplified from genomic DNA contained an intron. Upon sequencing the 2-kb fragment, we found 100% homology between these PCR products and the sequence of the human renal phosphate cDNA . Also, we detected donor (5' CTAGGTAGG) and acceptor (NCAGGG 3') splice site homologies and apparent intron sequences separat ing apparent exons of the genomic fragment.
Chromosomal localization. Figure I depicts the chromosomal localization of the renal phosphate gene using the somatic cell hybrid panel. A signal is seen on chromosome 5. No signal is seen on the X chromosome. Figure 2 depicts amplification of DNA from panel sets I and 2 of somatic cell hybrid DNA using the second set of primers, which were used to amplify the 2-kb genomic fragment. Both sets show amplifications corresponding to chromosome 5 (Bios Blot, New Haven, CT). Furthermore, we used the first set of primers to amplify a 600-bp genomic fragment. These primers also amplified somatic cell hybrid panel sets corresponding to chromosome 5 (data not shown).
Chromosomal sublocalization. The FISH technique was used
to sublocalize the phosphate transporter gene to chromosome 5. A total of 50 cells were scored in four runs of FISH. The only consistent site for hybridization was at 5q 13, which was seen in nine cells (Fig. 3) . Nonspecific background hybridization did not show any locus preference. No other locus was scored more than once.
Sublocalization was supported by G-banding (data not shown) and by comparing the ratio of centromere to hybridization signal distance on chromosome 5q divided by the length of chromosome 5q. An average ratio of 0.21 was calculated for our probe. This compares with the idiogram (International System for Human Cytogenetic Nomenclature, 1985) measurements of 0.19 for centromere to 5q13, 0.11 for centromere to 5q12, and 0.29 for centromere to 5q 14. Therefore, our average ratio of 0.21 is cation of the phosphate transporter gene (Bios-Map somatic cell hybrid Southern DNA, Bios Labs, New Haven, CT).
FISH. Metaphase chromosome spreads were prepared on glass microscope slides from peripheral blood lymphocyte cultures and stored in a desiccator at room temperature overnight. The slides were then treated with Ix RNase in 2x SSC pH 7.0 for I hat 37·C, dehydrated in a series of cold ethanol washes, and air dried. The slides were then denatured at 70·C for 2 min and immediately dehydrated through another series of cold ethanol washes, then air dried. The Fluorogreen (Amersham , Arlington Heights, IL) (fluorescein-II-deoxyuridine triphosphate)-Iabeled probe was denatured and added to a hybridization solution containing blocking agents and 60% formamide in 2x SSe. The labeled probe was then placed on the metaphase spreads, covered with glass coverslips that were sealed to prevent drying, and incubated in a humidified chamber at 37·C for 20-24 h. The slides were then washed through a series of 2x SSC washes, counterstained with propidium iodide diluted in Antifade (Oncor Inc.), sealed with a glass coverslip, and viewed on an Olympus BH-2 fluorescent microscope. G-banding was done by incubating the metaphase spreads with trypsin [0.5 mL in 40 mL of Isoton (Coulter Diagnostics, Hialeah , FL)] for 30 s, then rinsing with double-distiJIed water and staining with Wright's stain.
Sequencing of genomic DNA. The PCR products were subcloned into PCR-II vector with the TA cloning kit from Invitrogen. Sequencing of PCR products was carried out by the dideoxy chain termination technique using the sequenase version 2.0 (United States Biochemical Corp., Cleveland, OH) (12) . secondary to a circulating factor that inhibits the function of the sodium phosphate transporter (17) .
Studies of human kindreds with X-linked hypophosphatemic rickets found that the human hypophosphatemic rickets locus showed 10% recombination (Lod score = 4.82) from the DXS41 locus that had been assigned by in situ hybridization to Xp22.1-p21.3 (18) . Moreover, Machler et al. (19) found tighter linkage, 8 = 0.00 at Lod = 5.084, indicating that the human hypophosphatemic rickets locus is on the X chromosome in the region of Xp22.l-p21.3.
Because the defect in hypophosphatemic vitamin D-resistant rickets is considered to be related to decreased activity or number of renal Na" phosphate transporters (7, II, 16, 17) ,we postulated that the gene for the renal phosphate transporter would be located at the X chromosome. Our results demonstrate that the human renal phosphate transporter does not reside on the human X chromosome but rather on chromosome 5. Nonsynteny between the Hyp and human renal phosphate transporter loci is compatible with two possibilities. First, perhaps the cloned Na" phosphate transporter is not involved in the pathogenesis of hypophosphatemic vitamin D-resistant rickets and the disease is caused by defects at another phosphate transporter locus that resides on the X chromosome. Examples of such isoforrns of transporters have been described recently for the Na"/H+ exchangers (20) . Na"/H+ exchanger I (NHE-I) is localized at chromosome I (21), whereas NHE-3 is localized at chromosome 5 (22) . Second, it is conceivable that a gene at the X chromosome is involved in the regulation of the phosphate transporter located on chromosome 5 and its derangement causes hypophosphatemic rickets through an epistatic effect.
Our observation should focus further investigations on human hypophosphatemic rickets.
Note added in proof After the submission of our manuscript, Kos et al. presented an abstract (Am Soc Nephro1 4:72P, 1993) in which the Nat-phosphate transporter eDNA was mapped to 5q35. Although the chromosomal localization is similar to ours, the sublocalization appears different. 
